Would you trust a chatbot with a serious health issue?

Summary

Turney Duff puts it to the panel as a flag question, and nobody gives a clean answer. Mario Tufano, Senior Portfolio Manager at CS McKee, uploads his own blood results and still will not let a model near a decision about a biopsy. Drew Pettit, Chief Investment Strategist at Roundhill Investments, uses it to work out what to ask his doctor. Emily Peck of Axios has the analogy for where the line sits. Then Tufano lands the thing nobody else says: the product is built to keep you there, so it compliments you. The last three minutes are the four of them describing what they actually use it for…

Description from Yahoo News.